Global Liquid
Chromatography Mass Spectrometry (LCMS) Market, by Type (Single Quadrupole
LC-MS, Triple Quadrupole LC-MS, and Ion Trap LC-MS), by Sensitivity (High Flow,
Micro Flow, and Nano Flow), by End User (Biotechnology and Pharmaceutical
Industry, Hospital and Research Laboratories, and Academic and Research
Institutes), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) it is expected to be valued at US$ 3,683.7 million in
2019, and is expected to exhibit a CAGR of 12.0% over the forecast period (2019
– 2027), as highlighted in a new report published by.
Increasing research and
development expenditure in the healthcare sector and increasing product
launches by market players are expected to drive the market growth Increasing
product launches by market players, in order to offer advanced solutions for
efficient analysis of samples in the biotechnology and pharmaceutical industry,
and other sectors is expected to drive the liquid chromatography mass
spectrometry market growth. For instance, in June 2017, Thermo Fisher launched
a fully automated analyzer, Cascadion SM clinical analyzer system with
selectivity and sensitivity of liquid chromatography-tandem mass spectrometry
(LC-MS/MS). The fully automated analyzer can be customized easily to be
compatible with the laboratory information systems. Moreover, initiatives taken
by regulatory authorities regarding adoption of LCMS technique for testing and
analysis in the biopharmaceutical industry is expected to drive growth of the
LCMS market over the forecast period. For instance, in October 2019, the U.S.
Food and Drug Administration (FDA) recommended pharmaceutical companies to use
Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) for testing
N-nitrosodimethylamine (NDMA) in ranitidine products. The NDMA is found to be
carcinogenic in nature.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3102
Browse 28 Market Data Tables and
23 Figures spread through 186 Pages and in-depth TOC on ‘Liquid Chromatography
Mass Spectrometry (LCMS) Market’- Global Forecast to 2027, by Type (Single
Quadrupole LC-MS, Triple Quadrupole LC-MS, and Ion Trap LC-MS), by Sensitivity
(High Flow, Micro Flow, and Nano Flow), by End User (Biotechnology and
Pharmaceutical Industry, Hospital and Research Laboratories, and Academic and
Research Institutes), and by Region (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa)
Furthermore, key players and
other organizations are focused on strategic collaborations to offer training
programs for researchers, scientists, and other personnel, in order to boost
drug discovery in emerging economies. For instance, in August, 2019, Jomo Kenyatta
University of Agriculture and Technology (JKUAT), Kenya held a training session
for researchers from ten African countries for liquid chromatography mass
spectrometry (LC-MS) training, to help analyze live molecules in food,
medicine, and organic compounds. The training was co-funded by the Royal
Society of Chemistry (RSC) and GlaxoSmithKline (GSK), and the Pan Africa
Chemistry Network (PACN). The key players operating in the market are focused
on adopting acquisition and collaboration strategies, in order to expand their
product offerings in potential markets. For instance, in September 2019, Thermo
Fisher Scientific Inc. and Cedars-Sinai entered a collaboration for developing
advanced liquid chromatography mass spectrometry workflows for screening and
targeted quantitation of protein-based biomarkers for complicated diseases.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/liquid-chromatography-mass-spectrometry-market-3102
Key Takeaways of the Liquid
Chromatography Mass Spectrometry Market:
The global liquid chromatography
mass spectrometry market is expected to exhibit a CAGR of 12.0% over the
forecast period, owing to product launches by market players. For instance, in
2018, Shimadzu Corporation launched Nexera Mikros, a micro flowrate-compatible
liquid chromatograph mass spectrometer which provides ten times higher
sensitivity.
On the basis of sensitivity, the
micro flow segment held a dominant position in the liquid chromatography mass
spectrometry market in 2018, owing to its vast application in research which
includes proteomics, biomarker discovery, bioanalysis, and environmental
analysis, which is attributed to its higher sensitivity
Among end user, the biotechnology
and pharmaceutical industries segment held a dominant position in the liquid
chromatography mass spectrometry market in 2018, owing to increasing
innovations to accelerate drug development. For instance, in May 2018, SCIEX
launched BioPharmaView Software 3.0 solution for complete LC-MS multiple
attribute methodology (MAM) workflow, which enables detailed characterization
of biologics for use by biopharma researchers.
Key players operating in the
global liquid chromatography mass spectrometry market include Danaher
Corporation, PerkinElmer, Inc., Waters Corporation, Bruker Corporation, Thermo
Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, JEOL
Ltd., and Newomics, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3102
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment